0001415889-21-002957.txt : 20210611
0001415889-21-002957.hdr.sgml : 20210611
20210611163007
ACCESSION NUMBER: 0001415889-21-002957
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210611
DATE AS OF CHANGE: 20210611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Kinney
CENTRAL INDEX KEY: 0001831215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 211011662
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
form4-06112021_010653.xml
X0306
4
2021-06-10
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001831215
Horn Kinney
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
false
true
false
false
CHIEF BUSINESS OFFICER
Common Stock
2021-06-10
4
M
0
5251
2.064
A
7041
D
Common Stock
2021-06-10
4
S
0
300
28.30
D
6741
D
Common Stock
2021-06-10
4
S
0
2164
29.60
D
4577
D
Common Stock
2021-06-10
4
S
0
2787
29.97
D
1790
D
Stock Option (right to buy)
2.064
2021-06-10
4
M
0
5251
0
D
2030-06-09
Common Stock
5251
189046
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The weighted average sale price for the transaction reported was $28.30, and the range of prices were between $27.79 and $28.63. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $29.60, and the range of prices were between $28.81 and $29.80. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $29.97, and the range of prices were between $29.82 and $30.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2021-06-11